ZAWSAI AUNG: Open Payments
NPI 1467795344 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 25 payments from 12 companies in 2025. Trend: 2023 $402 · 2024 $564 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $120 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| Lilly USA, LLC | 4 | $67 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| SHIELD THERAPEUTICS INC | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| ABBVIE INC. | 2 | $30 |
| Corcept Therapeutics | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
Products named: BREZTRI, MOUNJARO, GARDASIL 9, ACCRUFER, XIFAXAN, JARDIANCE, Korlym, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
